Summary
The potencies as β-adrenoceptor blockers of KL 1006 (the N-isopropyl analogue of bupranolol), pindolol, propranolol and carazolol were compared with potencies of their corresponding tert. butyl analogues bupranolol, tert. butylpindolol, tert. butylpropranol and ter. butylcarazolol.
Experiments were carried out at 32.5° C in rat right atria — assessing β-adrenoceptor dependent chronotropic effects — and kitten ventricular membranes — assessing β-adrenoceptor dependent stimulation of adenylyl cyclase — from reserpine pretreated animals.
-
1.
The effects of (−)-isoprenaline on these two systems were antagonized competitively by each of the 8 ligands.
-
2.
None of the 8 ligands caused stimulation or depression of basal adenylyl cyclase activity at concentrations causing antagonism of the effects of (−)-isoprenaline.
-
3.
Pindolol, tert. butylpindolol, carazolol and tert. butylcarazolol were weak partial agonists in rat atria. concentrations of these ligands for producing significant stimulation were higher than those causing significant antagonism of the chronotropic effects of (−)-isoprenaline.
-
4.
Bupranolol, tert. butylpindolol, tert. butylpropranolol and tert. butylcarazolol were 6.6, 3.0, 3.2 and 1.1. times more potent as β-adrenoceptor antagonists in rat atria than their corresponding N-isopropyl analogues, respectively.
-
5.
Bupranolol, tert. butylpindolol, tert. butylpropranolol and tert. butylcarazolol were 4.8, 3.0, 2.7 and 0.6 times more potent as β-adrenoceptor antagonists in kitten membranes than their corresponding N-isopropyl analogues, respectively.
-
6.
The enhanced affinity for myocardial β-adrenoceptors of N-tert. butyl ligands (with respect to the affinity of the corresponding N-isopropyl ligands) appears to be inversely correlated with the size of the ring of the ligands.
Similar content being viewed by others
References
Åblad, B., Brogård, M., Ek, L.: Pharmacological properties of H56/28 — a β-adrenergic receptor antagonist. Acta Pharmacol. Toxicol. (Kbh.) 25, Suppl. 2, 9–40 (1967)
Ahlquist, R. P.: A study of the adrenotropic receptors. Am. J. Physiol. 153, 586–599 (1948)
Arunlakshana, O., Schild, H. O.: Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14, 48–58 (1959)
Barrett, A. M., Carter, J.: Comparative chronotropic activity of β-adrenoceptive antagonists. Br. J. Pharmacol. 40, 373–381 (1970)
Bilski, A. J., Wale, J. L.: Two types of intrinsic sympathomimetic activity with β-adrenoceptor blocking drugs. Br. J. Pharmacol. 56, 362P (1976)
Birnbaumer, L., Kaumann, A. J.: Attempts at modeling a β-adrenoceptor-responsive adenylyl cyclase system. Proceedings of the VIth International Symposium on Medicinal Chemistry, (M. A. Simkins, ed.), Oxford: Costwold Press, in press 1979
Black, J. W., Stephenson, J. S.: Pharmacology of a new adrenergic β-receptor blocking compound (Nethalide). Lancet 1962 II, 311–314
Black, J. W., Crowther, A. F., Shanks, R. G., Dornhorst, A. C.: A new adrenergic β-receptor antagonist. Lancet 1964 II, 1080–1081
Black, J. W., Duncan, W. A. M., Shanks, P. G.: Comparison of some properties of pronethalol and propranolol. Br. J. Pharmacol. 25, 577–591 (1965)
Brunner, H., Hedwall, P. R., Meier, M.: Pharmakologische Untersuchungen mit 1-Isopropylamino-3-(O-allyloxyphenoxy)-2-propanol-hydrochlorid, einem adrenergischen β-Rezeptorenblocker. Arzneim.-Forsch. 18, 164–170 (1968)
Carlsson, E., Åblad, B., Brändström, A., Carlsson, B.: Differentiated blockade of the chromotropic effects of various adrenergic stimuli in the cat heart. Life Sci. 11, 953–958 (1972)
Cheymol, G., Honnorat, C., Schmitt, H.: Pharmacological effects of two new β-adrenoceptor blocking drugs: Kö 1366 and Kö 1313. Eur. J. Pharmacol. 17, 341–351 (1972)
Crowther, A. F., Howe, R., McLoughlin, B. J., Mallion, K. B., Smith, L. H., Turner, R. W.: β-Adrenergic blocking agents. 12. Heterocyclic compounds related to propranolol. J. Med. Chem. 15, 260–266 (1972)
Femmer, K., Bürkner, U., Grünheid, K., Röllig, H.: Struktur-Wirkungsbeziehungen bei Phenoxyalkanolaminderivaten mit selektiver β1-Rezeptorenblockade. Pharmazie 30, 638–642 (1975)
Fothergill, G. A., Francis, R. J., Hamilton, T. C., Osbond, J. M., Parkes, M. W.: Bufuralol, a new β-adrenoceptor blocking agent. Experientia 31, 1322–1323 (1975)
Giudicelli, J. F., Schmitt, H., Boissier, J. R.: Studies on dl-4-(2-hydroxy-3-isopropylamino-propoxy)-indole (LB 46), a new potent β-adrenergic blocking compound. J. Pharmacol. Exp. Ther. 168, 116–126 (1969)
Kaplan, H. R., Lasala, S. A., Robson, R. D.: Oral β-adrenoceptor blocking activity of bunolol and its optical isomers. Eur. J. Pharmacol. 16, 237–240 (1971)
Kaumann, A. J.: Potentiation of the effects of isoprenaline and noradrenaline by hydrocortisone in cat heart muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 134–153 (1972)
Kaumann, A. J.: Adrenergic receptors of cardiac muscle: Two different mechanisms of β-blockers as partial agonists. Internat. Union of Biochemistry, Symposium No. 52, Acta Physiol. Lat.-Am. 32, 235–236 (1973)
Kaumann, A. J.: Some differences between heart β-adrenoceptors of reserpine-pretreated rats (Wistar II) and frogs (Xenopus laevis). Naunyn-Schmiedeberg's Arch. Pharmacol. 297, R49 (1977a)
Kaumann, A. J.: Relaxation of heart muscle by catecholamines and by dibutyryl cyclic adenosine 3′,5′-monophosphate. Similarity of β-adrenoceptors mediating contractile and relaxant effects of catecholamines in kitten papillary muscle. Naunyn-Schmiederg's Arch. Pharmacol. 296, 205–215 (1977b)
Kaumann, A. J.: On spare β-adrenoceptors for intropic effects of catecholamines in kitten ventricle. Naunyn-Schmiedeberg's Arch. Pharmacol. 305, 97–102 (1978)
Kaumann, A. J., Birnbaumer, L.: Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase. Stereospecificity and determination of apparent affinity constants for β-blockers. J. Biol. Chem. 249, 7874–7885 (1974)
Kaumann, A. J., Blinks, J. R.: Comparative potencies of β-adrenergic blocking agents on isolated heart muscle. Fed. Proc. 26, 401 (1967)
Kaumann, A. J., Bojar, H.: Relationship between the cellular number of occupied β-adrenoceptors and inotropic effects of catecholamines in hearts of reserpine-pretreated kittens. Proc. 7th International Congress of Pharmacology, p. 916, Paris, July 16–21, 1978
Kaumann, A. J., Friedenthal, M., Blinks, J. R.: Análisis de la acción bloqueante de antagonistas β-adrenérgicos en músculo cardíaco aislado. Medicina (B. Aires) 30, 596–597 (1970)
Kaumann, A. J., Wittmann, R., Birnbaumer, L., Hoppe, B. H.: Activation of myocardial β-adrenoceptors by the nitrogen-free low affinity ligand 3′,4′-dihydro-2-methylpropiophenone (U-0521). Naunyn-Schmiedeberg's Arch. Pharmacol. 296, 217–228 (1977)
Kaumann, A. J., Birnbaumer, L., Wittmann, R.: Heart β-adrenoceptors. In: Receptors and Hormone Action, Vol. III, pp. 133–177, (O'Malley, B. W., Birnbaumer, L., eds.). New York: Academic Press 1978
Kenakin, T. P., Black, J. R.: The pharmacological classification of practolol and chloropractolol. Mol. Pharmacol. 14, 607–623 (1978)
Lemoine, H., Kaumann, A. J.: The affinity of carazolol for myocardial and tracheal β-adrenoceptors activated by (−)-isoprenaline. Naunyn-Schmiedeberg's Arch. Pharmacol. 302, P53 (1978)
Levy, B.: Comparison of the β-receptor blocking properties of two analogs of dichloroisoproterenol (DCI). J. Pharmacol. Exp. Ther. 186, 123–133 (1973)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)
Marano, M., Kaumann, A. J.: On the statistics of drug-receptor constants for partial agonists. J. Pharmacol. Exp. Ther. 198, 518–525 (1976)
Marsh, D. F., Pelletier, M. H., Ross, C. A.: The comparative pharmacology of the N-alkylarterenols. J. Pharmacol. Exp. Ther. 92, 108–120 (1948)
Meyer, R. F., Stratton, C. D., Hastings, S. G., Corey, R. M.: β-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines. J. Med. Chem. 16, 1113–1116 (1973)
Moran, N. C., Perkins, M. E.: Adrenergic blockade of the mammalian heart by a dichoro analogue of isoproterenol. J. Pharmacol. Exp. Ther. 124, 223–237 (1978)
Morris, T. H., Birnbaumer, L., Kaumann, A. J.: High affinity of carazolol for β-adrenoceptors coupled to the adenylyl cyclase in ventricular myocardium of kitten and Xenopus laevis. Naunyn-Schmiedeberg's Arch. Pharmacol. 303, 295–297 (1978)
Mylecharane, E. J., Raper, C.: β-Receptor blocking and cardiodepressant actions of 2-cyanophenoxypropanolamines. Eur. J. Pharmacol. 16, 14–20 (1971)
Nakanishi, M., Muro, T., Chihara, H., Imamura, H., Nakao, T.: Studies on cardiovascular drugs. 5. 1-amino-3-phenoxy-2-propanol derivatives as β-adrenergic blocking agents. J. Med. Chem. 15, 45–48 (1972)
Powell, C. E., Slater, I. H.: Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J. Pharmacol. Exp. Ther. 122, 480–488 (1958)
Salomon, Y., Londos, C., Rodbell, M.: A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541–548 (1974)
Schweiger, J., Nicolescu, R. F., Rahn, K. H.: Quantitative Bestimmung der β-Rezeptorenblockade bein Menschen. Verh. Dtsch. Ges. Inn. Med. 78, 1544–1547 (1972)
Scriabine, A., Torchiana, M. L., Stavorski, J. M., Ludden, C. T., Minsker, D. H., Stone, C. A.: Some cardiovascular effects of timolol, a new β-adrenergic blocking agent. Arch. Int. Pharmacodyn. 205, 76–93 (1973)
Stephenson, R. P.: A modification of receptor theory. Br. J. Pharmacol. 11, 379–393 (1956)
Weinstock, L. M., Mulvey, D. M., Tull, R.: Synthesis of the β-adrenergic blocking agent timolol from optically active precursors. J. Org. Chem. 41, 3121–3124 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaumann, A.J., Morris, T.H. & Birnbaumer, L. A comparison of the influence of N-isopropyl and N-tert butyl substituents on the affinity of ligands for sinoatrial β-adrenoceptors in rat atria and β-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle. Naunyn-Schmiedeberg's Arch. Pharmacol. 307, 1–8 (1979). https://doi.org/10.1007/BF00506545
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00506545